Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02887235
Official study title

Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

Study summary

The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedHome Delivered, Medically Tailored Meals (HDTM)

The study team can explain what participation involves.

Who it may be forMetastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 9, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?NYU Langone Health

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
NYU Langone Health
Interventions being studied
Other: Home Delivered, Medically Tailored Meals (HDTM)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Metastatic or stage IV→
Study topics
Survivorship and quality of life→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Diagnosis of pathologically confirmed metastatic pancreatic, hepatobiliary, esophageal, or lung cancer, either newly metastatic or metastatic at presentation (M1+) and enrollment within 6 weeks of diagnosis; measurable disease need not be present.
  • Pain Score (PS) 0-3
  • Age\>18
  • Both male and female subjects eligible
  • All ethnicities eligible
  • Access to refrigerator or freezer
Reasons someone may not be able to joinExclusion criteria
  • Diagnosis of metastatic cancer no greater than 6 weeks prior to expected study enrollment
  • Currently receiving home delivered meals from other sources
  • Evidence of any alimentary tract obstruction or other condition preventing oral alimentation
  • Requirement for enteral or parenteral nutrition at time of diagnosis
  • Incarcerated individuals

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • NYU Perlmutter Cancer CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 9, 2020. Always confirm current availability with the study team.

View original record ↗